Results 11 to 20 of about 3,431,121 (50)

ID2 secures cDC1 specification by antagonizing E proteins at a pleiotropic Zeb2 enhancer. [PDF]

open access: yesNat Immunol
Ou F   +10 more
europepmc   +1 more source

BCLX<sub>L</sub> blockade rewires cell fate to overcome PARP inhibitor resistance in ovarian cancer. [PDF]

open access: yesSignal Transduct Target Ther
Venkatachalam A   +25 more
europepmc   +1 more source

Inorganic polyphosphate chelates Ca<sup>2+</sup> but cannot substitute for ATP as an energy source for SERCA. [PDF]

open access: yesBiochem Biophys Rep
Khasanov FA   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy